CYTL1 and gastric cancer: Furthermore, our study identified the hsa-miR-339-5p as miRNA target of CYTL1 which has previously been recognized as a suppressor of malignant development in gastric cancer thereby further cementing CYTL1 role as an oncogenic molecule in gastric cancer (75).